Loading, please wait.
8482 - 13460 Homo sapiens - Deletions Deletion length: 4977 bp Does not remove any origin of replication Inside the major arc |
Breakpoint flanking sequences more information in Documentation - Flanking regions |
||||||||||||
|
Two-dimensional scatterplot showing the location of the selected deletion (red diamond) versus the full dataset (grey dots). Each point represents an mtDNA rearrangement with the 5’ breakpoint on the x-axis and the 3’ breakpoint on the y-axis. |
Circular mtDNA plot specifying the location of the deleted region (black bar). |
Length distribution of the deleted region in the selected deletion (red bar) versus the full dataset (grey bars) .The cases were grouped 100-nt windows. |
References
[2] Goios, A., et al., mtDNA single macrodeletions associated with myopathies: absence of haplogroup-related increased risk. Journal of Inherited Metabolic Disease. 2005. 28(5): p. 769-78.
[6] Bodyak, N.D., et al., Quantification and sequencing of somatic deleted mtDNA in single cells: evidence for partially duplicated mtDNA in aged human tissues. Human Molecular Genetics. 2001. 10(1): p. 17-24.
[11] Degoul, F., et al., Different Mechanisms Inferred from Sequences of Human Mitochondrial-DNA Deletions in Ocular Myopathies. Nucleic Acids Research. 1991. 19(3): p. 493-496.
[18] Ferlin, T., et al., Detection of mitochondrial DNA deletions by a screening procedure using the polymerase chain reaction. Molecular and Cellular Biochemistry. 1997. 174(1-2): p. 221-225.
[21] Hsieh, R.H., et al., Multiple rearrangements of mitochondrial DNA in unfertilized human oocytes. Fertility and Sterility. 2002. 77(5): p. 1012-7.
[22] Jansson, M., et al., Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy. Acta Neuropathologica. 2000. 100(1): p. 23-8.
[24] Moslemi, A.R., C. Lindberg, and A. Oldfors, Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Human Mutation. 1997. 10(5): p. 381-6.
[25] Samuels, D.C., E.A. Schon, and P.F. Chinnery, Two direct repeats cause most human mtDNA deletions. Trends in Genetics. 2004. 20(9): p. 393-8.
[27] Kao, S.H., H.T. Chao, and Y.H. Wei, Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa. Molecular Human Reproduction. 1998. 4(7): p. 657-66.
[32] Kraytsberg, Y., et al., Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nature Genetics. 2006. 38(5): p. 518-20.
[33] Reeve, A.K., et al., Nature of mitochondrial DNA deletions in substantia nigra neurons. American Journal of Human Genetics. 2008. 82(1): p. 228-35.
[40] Mita, S., et al., Recombination Via Flanking Direct Repeats Is a Major Cause of Large-Scale Deletions of Human Mitochondrial-DNA. Nucleic Acids Research. 1990. 18(3): p. 561-567.
[41] Moraes, C.T., et al., Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions. Nature Genetics. 1992. 1(5): p. 359-67.
[42] Nakase, H., et al., Transcription and Translation of Deleted Mitochondrial Genomes in Kearns-Sayre Syndrome - Implications for Pathogenesis. American Journal of Human Genetics. 1990. 46(3): p. 418-427.
[44-47] Tengan, C.H., et al., Frequency of duplications in the D-loop in patients with mitochondrial DNA deletions. Biochimica Et Biophysica Acta. 2002. 1588(1): p. 65-70.
[49] Maximo, V., et al., Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. American Journal of Pathology. 2002. 160(5): p. 1857-65.
[76] Ito, M., et al., Screening for mitochondrial DNA heteroplasmy in children at risk for mitochondrial disease. Mitochondrion. 2001. 1(3): p. 269-78.
[107] Rotig, A., et al., Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Human Molecular Genetics. 1995. 4(8): p. 1327-30.
[110] Tanaka, M., et al., Direct sequencing of deleted mitochondrial DNA in myopathic patients. Biochemical and Biophysical Research Communications. 1989. 164(1): p. 156-63.
[116] Rotig, A., et al., Site-specific deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome. Genomics. 1991. 10(2): p. 502-4.
[119] Johns, D.R., et al., Directly repeated sequences associated with pathogenic mitochondrial DNA deletions. Proceedings of the National Academy of Sciences of the United States of America. 1989. 86(20): p. 8059-62.
[120] Hsieh, R.H., et al., Age-dependent respiratory function decline and DNA deletions in human muscle mitochondria. Biochemistry and Molecular Biology International. 1994. 32(6): p. 1009-22.
[121] Yen, T.C., et al., Age-dependent increase of mitochondrial DNA deletions together with lipid peroxides and superoxide dismutase in human liver mitochondria. Free Radical Biology and Medicine. 1994. 16(2): p. 207-14.
[125] Rotig, A., et al., Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. Journal of Clinical Investigation. 1990. 86(5): p. 1601-8.
[127] Boles, R.G., E.E. Baldwin, and T.R. Prezant, Combined cyclic vomiting and Kearns-Sayre syndromes. Pediatric Neurology. 2007. 36(2): p. 135-6.
[138] Moraes, C.T., et al., Phenotype-genotype correlations in skeletal muscle of patients with mtDNA deletions. Muscle & Nerve. 1995. 3: p. S150-3.
[147] Remes, A.M., et al., Mitochondrial DNA deletions in dilated cardiomyopathy: a clinical study employing endomyocardial sampling. Journal of the American College of Cardiology. 1994. 23(4): p. 935-42.
[148] Markaryan, A., E.G. Nelson, and R. Hinojosa, Detection of mitochondrial DNA deletions in the cochlea and its structural elements from archival human temporal bone tissue. Mutation Research. 2008. 640(1-2): p. 38-45.
[153] Chabi, B., et al., Quantification of mitochondrial DNA deletion, depletion, and overreplication: application to diagnosis. Clinical Chemistry. 2003. 49(8): p. 1309-17.
[154] Degoul, F., et al., Deletions of mitochondrial DNA in Kearns-Sayre syndrome and ocular myopathies: genetic, biochemical and morphological studies. Journal of the Neurological Sciences. 1991. 101(2): p. 168-77.
[159] Lebrecht, D., et al., Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. The Journal of Pathology. 2005. 207(4): p. 436-44.
[162] Zhang, C., et al., Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome. Human Molecular Genetics. 1995. 4(4): p. 751-4.
[163] Zhang, C., et al., Multiple Mitochondrial-DNA Deletions in an Elderly Human Individual. FEBS Letters. 1992. 297(1-2): p. 34-38.
[168] Carrozzo, R., et al., Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology. 1998. 50(1): p. 99-106.
[174] Vu, T.H., et al., Analysis of mtDNA deletions in muscle by in situ hybridization. Muscle & Nerve. 2000. 23(1): p. 80-5.
[175] Pang, C.Y., et al., Human skin mitochondrial DNA deletions associated with light exposure. Archives of Biochemistry and Biophysics. 1994. 312(2): p. 534-8.
[176] Moslemi, A.R., et al., Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Annals of Neurology. 1996. 40(5): p. 707-713.
[177] Mohri, I., et al., A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up. Journal of the Neurological Sciences. 1998. 158(1): p. 106-9.
[178] Shoffner, J.M., et al., Spontaneous Kearns-Sayre Chronic External Ophthalmoplegia Plus Syndrome Associated with a Mitochondrial-DNA Deletion - a Slip Replication Model and Metabolic Therapy. Proceedings of the National Academy of Sciences of the United States of America. 1989. 86(20): p. 7952-7956.
[179] Bernes, S.M., et al., Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. Journal of Pediatrics. 1993. 123(4): p. 598-602.
[180] Blanchard, B.J., et al., A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue. NeuroReport. 1993. 4(6): p. 799-802.
[181] Bourgeron, T., et al., Fate and expression of the deleted mitochondrial DNA differ between human heteroplasmic skin fibroblast and Epstein-Barr virus-transformed lymphocyte cultures. Journal of Biological Chemistry. 1993. 268(26): p. 19369-76.
[182] Brockington, M., et al., A tandem duplication in the D-loop of human mitochondrial DNA is associated with deletions in mitochondrial myopathies. Nature Genetics. 1993. 4(1): p. 67-71.
[183] Corral-Debrinski, M., et al., Mitochondrial-DNA Deletions in Human Brain - Regional Variability and Increase with Advanced Age. Nature Genetics. 1992. 2(4): p. 324-329.
[184] Corral-Debrinski, M., et al., Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics. 1994. 23(2): p. 471-6.
[185] Corral-Debrinski, M., et al., Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutation Research. 1992. 275(3-6): p. 169-80.
[186] Cortopassi, G.A. and N. Arnheim, Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Research. 1990. 18(23): p. 6927-33.
[187] DiDonato, S., et al., Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology. 1993. 43(11): p. 2262-8.
[188] Ernst, B.P., et al., Deletion screening of mitochondrial DNA via multiprimer DNA amplification. Molecular and Cellular Probes. 1994. 8(1): p. 45-9.
[189] Goto, Y., et al., Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. Journal of the Neurological Sciences. 1990. 100(1-2): p. 63-9.
[190] Gurgey, A., et al., Pearson's marrow-pancreas syndrome in 2 Turkish children. Acta Haematologica. 1992. 87(4): p. 206-9.
[191] Holt, I.J., et al., Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Annals of Neurology. 1989. 26(6): p. 699-708.
[192] Holt, I.J., A.E. Harding, and J.A. Morgan-Hughes,. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988. 331(6158): p. 717-9
[193] Holt, I.J., A.E. Harding, and J.A. Morgan-Hughes, Deletions of muscle mitochondrial DNA in mitochondrial myopathies: sequence analysis and possible mechanisms. Nucleic Acids Research. 1989. 17(12): p. 4465-9.
[194] Ikebe, S., et al., Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochemical and Biophysical Research Communications. 1990. 170(3): p. 1044-8.
[195] Johns, D.R., mtDNA deletions in Kearns-Sayre. Neurology. 1990. 40(8): p. 1322-3.
[196] Lee, H.C., et al., Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochimica Et Biophysica Acta. 1994. 1226(1): p. 37-43.
[197] Lestienne, P. and G. Ponsot, Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet. 1988. 1(8590): p. 885.
[198] Linnane, A.W., et al., Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochemistry International. 1990. 22(6): p. 1067-76.
[199] Mann, V.M., J.M. Cooper, and A.H. Schapira, Quantitation of a mitochondrial DNA deletion in Parkinson's disease. FEBS Letters. 1992. 299(3): p. 218-22.
[200] McShane, M.A., et al., Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. American Journal of Human Genetics. 1991. 48(1): p. 39-42.
[201] Mita, S., et al., Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proceedings of the National Academy of Sciences of the United States of America. 1989. 86(23): p. 9509-13.
[202] Moraes, C.T., et al., Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. The New England Journal of Medicine. 1989. 320(20): p. 1293-9.
[203] Muller-Hocker, J., et al., Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibres in the elderly. Virchows Archive A, Pathological Anatomy and Histopathology. 1993. 422(1): p. 7-15.
[204] Niaudet, P., et al., Deletion of the mitochondrial DNA in a case of de Toni-Debre-Fanconi syndrome and Pearson syndrome. Pediatric Nephrology. 1994. 8(2): p. 164-8.
[205] Obermaier-Kusser, B., et al., Different copy numbers of apparently identically deleted mitochondrial DNA in tissues from a patient with Kearns-Sayre syndrome detected by PCR. Biochemical and Biophysical Research Communications. 1990. 169(3): p. 1007-15.
[206] Ozawa, T., et al., Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochemical and Biophysical Research Communications. 1990. 172(2): p. 483-9.
[207] Poulton, J., et al., Germ-line deletions of mtDNA in mitochondrial myopathy. American Journal of Human Genetics. 1991. 48(4): p. 649-53.
[208] Rotig, A., et al., Deletion of blood mitochondrial DNA in pancytopenia. Lancet. 1988. 2(8610): p. 567-8.
[209] Rotig, A., et al., Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet. 1989. 1(8643): p. 902-3.
[210] Anan, R., et al., Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation. 1995. 91(4): p. 955-61.
[211] Bai, U., et al., Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study. American Journal of Otolaryngology. 1997. 18(4): p. 449-53.
[212] Chen, X., et al., Paucity of deleted mitochondrial DNAs in brain regions of Huntington's disease patients. Biochimica Et Biophysica Acta. 1995. 1271(1): p. 229-33.
[213] Chen, X., et al., Rearranged mitochondrial genomes are present in human oocytes. American Journal of Human Genetics. 1995. 57(2): p. 239-47.
[214] Fassati, A., et al., Chronic progressive external ophthalmoplegia: a correlative study of quantitative molecular data and histochemical and biochemical profile. Journal of the Neurological Sciences. 1994. 123(1-2): p. 140-6.
[215] Fromenty, B., et al., Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology. 1995. 108(1): p. 193-200.
[216] Fukushima, S., et al., The frequency of 4977 base pair deletion of mitochondrial DNA in various types of liver disease and in normal liver. Hepatology. 1995. 21(6): p. 1547-51.
[217] Kao, S., H.T. Chao, and Y.H. Wei, Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biology of Reproduction. 1995. 52(4): p. 729-36.
[218] Keefe, D.L., et al., Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women. Fertility and Sterility. 1995. 64(3): p. 577-83.
[219] Kitagawa, T., et al., Rapid accumulation of deleted mitochondrial deoxyribonucleic acid in postmenopausal ovaries. Biology of Reproduction. 1993. 49(4): p. 730-6.
[220] Lee, H.C., et al., Ageing-associated tandem duplications in the D-loop of mitochondrial DNA of human muscle. FEBS Letters. 1994. 354(1): p. 79-83.
[221] Lezza, A.M., et al., Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochemical and Biophysical Research Communications. 1994. 205(1): p. 772-9.
[222] Muller-Hocker, J., U. Jacob, and P. Seibel, The common 4977 base pair deletion of mitochondrial DNA preferentially accumulates in the cardiac conduction system of patients with Kearns-Sayre syndrome. Modern Pathology. 1998. 11(3): p. 295-301.
[223] Sano, T., et al., Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome. Pediatric Research. 1993. 34(1): p. 105-10.
[224] Schon, E.A., et al., A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science. 1989. 244(4902): p. 346-9.
[225] Sciacco, M., et al., Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Human Molecular Genetics. 1994. 3(1): p. 13-9.
[226] Shanske, S., et al., Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology. 1990. 40(1): p. 24-8.
[227] Simonetti, S., et al., Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochimica Et Biophysica Acta. 1992. 1180(2): p. 113-22.
[228] Simonsz, H.J., K. Barlocher, and A. Rotig, Kearns-Sayre's syndrome developing in a boy who survived pearson's syndrome caused by mitochondrial DNA deletion. Documenta Ophthalmologica. 1992. 82(1-2): p. 73-9.
[229] Soong, N.W., et al., Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genetics. 1992. 2(4): p. 318-23.
[230] Suganuma, N., et al., Human ovarian aging and mitochondrial DNA deletion. Hormone Research. 1993. 39 Suppl 1: p. 16-21.
[231] Ueda, N., et al., Mitochondrial DNA deletion is a predisposing cause for sensorineural hearing loss. Laryngoscope. 1998. 108(4 Pt 1): p. 580-4.
[232] Wang, H., et al., Quantification of mitochondrial DNA in heteroplasmic fibroblasts with competitive PCR. Biotechniques. 1994. 17(1): p. 76-8, 80, 82
[233] Yang, J.H., et al., A specific 4977-bp deletion of mitochondrial DNA in human ageing skin. Archives of Dermatological Research. 1994. 286(7): p. 386-90.
[234] Zeviani, M., et al., Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology. 1988. 38(9): p. 1339-46.
[235] Brenner, C.A., et al., Mitochondrial DNA deletion in human oocytes and embryos. Molecular Human Reproduction. 1998. 4(9): p. 887-92.
[236] Lewis, P.D., et al., Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. The Journal of Pathology. 2000. 191(3): p. 274-81.
[237] Maximo, V., et al., The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastructural Pathology. 1998. 22(3): p. 271-3.
[238] Meissner, C. and N. von Wurmb, Sensitive detection of the 4977-bp deletion in human mitochondrial DNA of young individuals. Biotechniques. 1998. 25(4): p. 652-4.
[239] Porteous, W.K., et al., Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. European Journal of Biochemistry. 1998. 257(1): p. 192-201.
[240] Barritt, J.A., et al., Spontaneous and artificial changes in human ooplasmic mitochondria. Human Reproduction. 2000. 15 Suppl 2: p. 207-17.
[241] Dai, P., et al., Correlation of cochlear blood supply with mitochondrial DNA common deletion in presbyacusis. Acta Oto-laryngologica. 2004. 124(2): p. 130-6.
[242] Garcia-Cazorla, A., et al., Mitochondrial diseases associated with cerebral folate deficiency. Neurology. 2008. 70(16): p. 1360-2.
[243] Lai, L.P., et al., Atrial fibrillation is associated with accumulation of aging-related common type mitochondrial DNA deletion mutation in human atrial tissue. Chest. 2003. 123(2): p. 539-44.
[244] Lewis, P.D., et al., Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia. The Journal of Pathology. 2000. 192(4): p. 562-3.
[245] Prithivirajsingh, S., et al., Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation. FEBS Letters. 2004. 571(1-3): p. 227-32.
[246] Ro, L.S., et al., Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: a hospital-based case-control study. Muscle & Nerve. 2003. 28(6): p. 737-43.
[247] Thayer, R.E., et al., A maternal line study investigating the 4977-bp mitochondrial DNA deletion. Experimental Gerontology. 2003. 38(5): p. 567-71.
[248] Zhang, B., et al., A study of mitochondrial DNA mutations in peripheral lymphocytes in an aging cohort. Biochemical Society Transactions. 2003. 31(2): p. 444-6.
[249] Berneburg, M., et al., Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. Journal of Investigative Dermatology. 2004. 122(5): p. 1277-83.
[250] Chan, C.C., et al., Mitochondrial DNA content and 4977 bp deletion in unfertilized oocytes. Molecular Human Reproduction. 2005. 11(12): p. 843-6.
[251] Dani, S.U., M.A. Dani, and A.J. Simpson, The common mitochondrial DNA deletion deltamtDNA(4977): shedding new light to the concept of a tumor suppressor mutation. Medical Hypotheses. 2003. 61(1): p. 60-3.
[252] Houshmand, M., et al., Investigation on mtDNA deletions and twinkle gene mutation (G1423C) in Iranian patients with chronic progressive external opthalmoplagia. Neurology India. 2006. 54(2): p. 182-5.
[253] Mawrin, C., et al., Single-cell analysis of mtDNA deletion levels in sporadic amyotrophic lateral sclerosis. NeuroReport. 2004. 15(6): p. 939-43.
[254] Pallotti, F., et al., Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. American Journal of Human Genetics. 1996. 59(3): p. 591-602.
[255] Pogozelski, W.K., et al., Quantification of total mitochondrial DNA and the 4977-bp common deletion in Pearson's syndrome lymphoblasts using a fluorogenic 5'-nuclease (TaqMan) real-time polymerase chain reaction assay and plasmid external calibration standards. Mitochondrion. 2003. 2(6): p. 415-27.
[256] Yen, T.C., et al., Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochemical and Biophysical Research Communications. 1991. 178(1): p. 124-31.
[257] Bai, U. and M.D. Seidman, A specific mitochondrial DNA deletion (mtDNA4977) is identified in a pedigree of a family with hearing loss. Hearing Research. 2001. 154(1-2): p. 73-80.
[258] Levin, B.C., et al., The common deletion found in patient reexamined after 33 years and comparison with complete mtDNA sequences of maternal relatives. Mitochondrion. 2005. 5(6): p. 403-10.
[259] Mkaouar-Rebai, E., et al., A case of Kearns-Sayre syndrome with two novel deletions (9.768 and 7.253 kb) of the mtDNA associated with the common deletion in blood leukocytes, buccal mucosa and hair follicles. Mitochondrion. 2010. 10(5): p. 449-55.
[260] Rao, M., et al., Mitochondrial DNA injury and mortality in hemodialysis patients. Journal of the American Society of Nephrology. 2009. 20(1): p. 189-96.
[261] Rossato, L.B., et al., Prevalence of 4977bp deletion in mitochondrial DNA from patients with chronic kidney disease receiving conservative treatment or hemodialysis in southern Brazil. Renal Failure. 2008. 30(1): p. 9-14.
[262] Tsai, H.D., et al., Mitochondria DNA deletion and copy numbers of cumulus cells associated with in vitro fertilization outcomes. The Journal of Reproductive Medicine. 2010. 55(11-12): p. 491-7.
[263] Villa, A., et al., Decrease of ultraviolet A light-induced "common deletion" in healthy volunteers after oral Polypodium leucotomos extract supplement in a randomized clinical trial. Journal of the American Academy of Dermatology. 2010. 62(3): p. 511-3.
[264] Ye, C., et al., Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases. Breast Cancer Res Treat. 2008. 108(3): p. 427-34.
[265] Rocher, C., et al., Base composition at mtDNA boundaries suggests a DNA triple helix model for human mitochondrial DNA large-scale rearrangements. Molecular Genetics and Metabolism. 2002. 76(2): p. 123-32.
[266] Hamblet, N.S. and F.J. Castora, Mitochondrial DNA deletion analysis: a comparison of PCR quantitative methods. Biochemical and Biophysical Research Communications. 1995. 207(2): p. 839-47.
[267] Maassen, J.A. and T. Kadowaki, Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia. 1996. 39(4): p. 375-82.
[325] Krishnan, K. J. and Birch-Machin, M. A., The incidence of both tandem duplications and the common deletion in mtDNA from three distinct categories of sun-exposed human skin and in prolonged culture of fibroblasts. The Journal of Investigative Dermatology. 2006. 126(2): p. 408-415.
[326] Hjelm, B.E., et al., . in preparation
[329] Vielhaber, Stefan, et al., Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathologica. 2013. 125(2): p. 245-256.
[330] Volmering, E., et al., Neuropathological signs of inflammation correlate with mitochondrial DNA deletions in mesial temporal lobe epilepsy. Acta Neuropathologica. 2016. 132(2): p. 277-288.
[333] Trifunov, S., et al., Clonal expansion of mtDNA deletions: different disease models assessed by digital droplet PCR in single muscle cells. Scientific Reports. 2018. 8(1): p. 11682.